PML/RARa is the abnormal protein product of the Acute Promyelocytic Leukemia-speci®c 15;17 translocation. Both the PML and RARa components are required for the PML/RARa biological activities, namely its capacity to block dierentiation and to increase survival of haematopoietic precursors. The physiological role of PML and its contribution to the function of the fusion protein are unknown. PML localizes to the cytoplasm and within speci®c nuclear bodies (NBs). In vitro, overexpression of PML correlates with suppression of cell transformation. The PML aminoterminal portion retained within the PML/RARa protein contains the RING ®nger, two newly de®ned cystein/histidine-rich motifs called Bboxes (B1 and B2) and a coiled-coil region. We report here that PML has a growth suppressive activity in all the cell lines tested, regardless of their transformed phenotype, and that the cellular basis for the PML growth suppression is induction of apoptotic cell death. Analysis of various nuclear and cytoplasmic PML isoforms showed that the PML growth suppressive activity correlates with its nuclear localization. Analysis of the localization and growth suppressive activity demonstrated that: (i) the Ring+B1-B2 and coiled-coil regions are both indispensable and sucient to target PML to the NBs; (ii) individual deletions of the various PML domains have no eect on its growth suppressor activity; (iii) the Ring+B1-B2 region exerts a partial growth suppressor activity but its fusion with the coiled-coil region is sucient to recapitulate the suppressive function of wild type PML. These results indicate that PML is involved in cell survival regulation and that the PML component of the fusion protein (Ring+B1-B2 and coiled-coil regions) retains intact biological activity, thereby suggesting that the eects of PML/RARa on survival derive from the activation of the incorporated PML sequence.
Introduction
The PML gene was identi®ed by cloning the breakpoint sites of the 15;17 chromosome translocation associated with acute promyelocytic leukaemia Borrow et al., 1990; de TheÂ et al., 1990) . It is localized on chromosome 15 and as a consequence of the translocation is fused with the retinoic acid receptor a gene (RARa) on 17. The PML/RARa fusion gene is transcriptionally active in all APL cases and encodes for a PML/RARa fusion protein (de TheÂ et al., 1991; Kakizuka et al., 1991; Pandol® et al., 1991) . PML/RARa transgenic mice develop haematopoietic alterations with typical APL phenotypic features (Grisolano et al., 1996; Brown et al., 1997) and expression of PML/RARa in chicken haematopoietic progenitors induces acute leukaemia (Altabef et al., 1996) . Ectopic expression of PML/ RARa into human haematopoietic cell lines blocks dierentiation induced by various stimuli and prolongs cell survival by inhibiting apoptosis Rogaia et al., 1995) , suggesting that these two biological activities underlie the leukaemogenic potential of PML/RARa in vivo. Extensive structure-function analysis has revealed that the integrity of both PML and RARa domains is crucial for the dierentiation block (Grignani et al., 1996) and the eect on cell survival (Ferrucci et al., 1997) .
The molecular mechanisms through which PML/ RARa exerts its biological activities are poorly understood. It has been proposed that the fusion protein has a dominant negative eect on PML and RARa endogenous pathways, since, in APL cells, it localizes in nuclear microspeckled structures and provokes delocalization of the endogenous PML and RXR, a RARa co-factor (Dyck et al., 1994; Flenghi et al., 1995; Koken et al., 1994; Weis et al., 1994) . Alternatively, PML/RARa biological activities might be the consequence of activation of both PML and RARa functional domains within the context of the fusion protein (Grignani et al., 1996) .
The physiological function and biochemical activities of the PML protein are unknown. PML belongs to a family of proteins which share an aminoterminal tripartite domain characterized by the C 3 HC 4 zinc ®nger motif, named Ring ®nger, one or two additional cysteine-rich regions (B-boxes) and a coiled-coil region Lovering et al., 1993; Reddy et al., 1992) . Many members of this family are transcriptional regulators, some display DNA binding function and two (RFP, T18/TIF1) are, like PML, involved in genetic recombinations that lead to the formation of transforming fusion proteins (RFP/ret and T18/B-raf, respectively) (Gandini and Pandol®, 1994; Le Douarin et al., 1995; Tkahashi et al., 1988) . The RING ®nger motif, the B-boxes and the coiled-coil regions are retained in the PML/RARa protein.
PML is a nuclear phosphoprotein and is localized to speci®c matrix-associated subdomains called nuclear bodies (PML-NB), also known as POD (PML oncogenic domains), ND10 (Nuclear Domain 10) or Kr bodies (Dyck et al., 1994; Everett and Maul, 1994; Weis et al., 1994) . Several proteins have been identi®ed that colocalize with PML within NBs: the SP100 protein, originally identi®ed as an autoantigen in patients with primary biliary cirrhosis (Szostecki et al., 1990) ; two proteins of unknown function of 65 kDa (Epstein, 1984) and 55 kDa (NDP55) (Ascoli and Maul, 1991) ; NP52 (Korioth et al., 1995) ; the PIC-1 PML interacting protein (Boddy et al., 1996) ; the retinoblastoma protein (Alcalay et al., 1998) and Int-6 (Desbois et al., 1996) . The PML-NBs are thought to be critical targets during viral infection. In fact, a drastic redistribution of the PML-NBs into ®brous structures has been shown to occur during infection by DNA viruses such as Herpes Simplex and Adenoviruses (Carvalho et al., 1995; Doucas et al., 1996; Everett and Maul, 1994; PuvionDutilleul et al., 1995) together with an increase in size and number after treatment of cells with interferon Lavau et al., 1995; .
PML overexpression suppresses the transformed phenotype in some experimental systems. It decreases the capacity of activated (neu) or cooperative oncogenes (Ha-Ras plus myc or mutated p53) to transform NIH3T3 cells and rat embryo ®broblasts, respectively Mu et al., 1994) , but has no eect on Ras transformation in the same cell types. As the localization of NBs is lost in various PML-non functional mutants, the anti-tumor eect seems to depend on the integrity of the NBs (Le et al., 1996) . Based on these data, it has been suggested that, in APL cells, the PML growth suppressive function is lost as a consequence of the fusion with RARa and that the resulting PML/RARa protein dominates over the endogenous PML by provoking its delocalization from the NBs (Le et al., 1996) . However, whether the ability of PML to suppress transformation in certain experimental systems re¯ects a more general function of growth suppression and whether and how this function is lost in APL remain to be established.
We report here that PML suppresses cell growth in all cell lines tested regardless of their transformed phenotype; that the mechanism of action is due to an induction of cellular death and that it depends on the cooperation of the PML domains retained by the PML/RARa fusion protein. These results have important implications for the physiological role of PML and the leukaemic activity of PML/RARa.
Results

PML overexpression suppresses growth in a variety of cell lines
To investigate the potential of PML to suppress cell growth we tested the capacity of several cell lines to form G418-resistant colonies in the presence of PML overexpression (colony formation assay). For this purpose both transformed cell lines (C33a and HeLa cervix carcinoma; SAOS-2 and U20S osteosarcoma) and normal ®broblasts (NIH3T3 and primary mouse ®broblasts) were used. All cell lines were transfected with a PML expression vector (PML3-pCDNA3; see methods) or the empty pCDNA3 expression vector and, after 15 days of G418 selection, stained with crystal violet and evaluated for the number of resistant colonies. There was a dramatic drop in the capacity of all the cell lines to form colonies in the presence of PML overexpression (Figure 1 ). The level of PML expression 48 h after transfection was high (not shown) but became very low or absent after selection, as evaluated by Western blotting of the rare G418-resistant colonies (not shown). These results demonstrates that PML has growth suppressive activity in all the cell lines tested regardless of their transformed phenotype. The antiproliferative eect appeared to be both Rb and p53 independent, since the C33a and HeLa cell lines, which both carry genetic and/or functional inactivation of p53 and Rb, were sensitive to the growth-suppressive action of PML3.
Inducible expression of PML3 in U937 cells induces cell death
To determine the mechanism through which PML exerts its growth suppressive function, PML was expressed under the control of the metallothionine (MT) zinc (Zn) inducible promoter (pMTPML3) in a variety of cell lines. However, inducible PML expression was obtained only in the U937 cell line. Several clones were derived from electroporated U937 cells and analysed by Western blotting for PML expression. Clone MTP#F1 was selected because the exogenous PML protein was not detectable prior to Zn induction, while high levels were documented after Zn (see panel inside Figure 2a ). The eect of PML overexpression on cell proliferation was evaluated by comparing the growth potential of one U937 cell clone carrying the MT empty expression vector (MT#8) and MTP#F1 cells. The growth rate of Zn-untreated Figure 1 Eects of PML expression on growth of a variety of human cell lines. Triplicates of cells from the indicated cell lines were transfected by calcium phosphate precipitation procedure with the empty pCDNA3 expression vector (C: control) or with the same plasmid carrying the PML3 isoform (PML: PML3 isoform). After 48 h from the transfection cells were splitted, diluted 1 : 25, 1 : 50 and 1 : 100 and re-plated in medium containing 500 mg/ml of G418. After 15 ± 21 days of antibiotic selection a crystal violet staining was perform to detect the surviving colonies. The results are expressed as percentage of cloning eciency with respect to the control empty expression vector MTP#F1 cells was comparable to those of Znuntreated and Zn-treated MT#8 control cells. It, therefore, appears that MTP#F1 cells grow as the control in the absence of Zn induction and that Zn treatment has not signi®cant eects on growth of U937 cells. However, Zn treatment of MTP#F1 cells almost completely blocked the expansion of the cell population, suggesting that PML overexpression prevents growth of U937 cells.
To determine the mechanism through which PML overexpression produces growth suppression, the cell cycle distribution and percentage of apoptotic cells was evaluated every 24 h in both the MT#8 control and MTP#F1 clones by¯ow cytometry of propidium iodide-stained nuclei and the TdT assay, respectively. FACS analysis revealed no marked variations in the proportion of cycling cells in control and PML populations (not shown). Instead, the TdT assay revealed that the percentage of positive cells was low in Zn-untreated and Zntreated MT#8 cells and in Zn-untreated MTP#Fl cells (approximately 2 ± 3%), during the 4 days of the culture. Instead, in the MTP#F1 cells, the number of TdT positive cells was high and constant during the 4 days of culture (approximately 20 ± 25%).
Taken together these data suggest that PML overexpression induces apoptotic cell death in U937 cells and that this eect depends on the levels of PML protein expression.
A PML isoform with cytoplasmic localization has no eects on cell growth PML is a nuclear protein with a minor component of cytoplasmic localization, as revealed by cell fractionation and immuno¯uorescence studies (Koken et al., 1994; Flenghi et al., 1995 and our unpublished results) . Several PML isoforms have been identi®ed which dier for their cellular localization. The PML 3-4-7 isoform lacks the putative nuclear localization signal (NLS) and is localized to the cytoplasm (Fagioli et al., 1992; Flenghi et al., 1995) . It contains the Ring+BI-B2 boxes, the coiled-coil region and a short tract of the predicted a-helix region ( Figure 3a ). All other PML isoforms (PML1, PML2, PML3 and PML4) are nuclear and dier in their carboxyterminal region (Fagioli et al., 1992; Flenghi et al., 1995) . Transient expression of the PML 3-4-7 cDNA into U20S yielded the expected 47 kDa a-PML immunoreactive polypeptide ( Figure 3b ). However, it lacked growth suppressive activity on the same cells, as revealed by the colony assay ( Figure 3c ). The PML3 (Figure 3c ), PML1 and PML2 (data not shown) isoforms gave comparable levels of growth inhibition. These results suggest that nuclear localization is a prerequisite of the PML growth suppressive activity.
Single deletions of the cysteine-histidine, coiled-coil or carboxy-terminal regions exert no eect on the PML growth suppressive activity To de®ne the regions responsible for the PML growth suppressive activity, we constructed PML mutants lacking the aminoterminal cysteine-histidine rich region containing the Ring+BI-B2 boxes (DCPML3), the coiled-coil region (DHPML3), or the carboxyterminal region (PML-Pr). This last mutant was engineered to contain the PML sequences which are retained within the PML/RARa fusion protein ( Figure  3a) . The DCPML3, DHPML3 and PML-PR mutants all localize to the nucleus. Their corresponding expression vector were then transfected into U20S cells to perform a colony formation assay. The levels of expression, as determined by Western blot analysis 48 h after transfection, were high and roughly the same for all mutants (see Figure 3b for representative results) but became low or absent after selection, as adjudged by Western blotting of the rare G418 resistant colonies (not shown). The results of the colony assays (Figure 3c ) showed that the PML growth suppressive activity was retained in the DCPML3 and PML-Pr mutants and partially reduced in the DHPML3 mutant. As the biological activity of PML was not signi®cantly aected by the deletion of the Ring plus B1-B2 boxes, coiled-coil or carboxyterminal region, these domains do not appear to be indispensable for the growth suppressor function of PML. Additive eects of dierent PML regions on growth suppression
Since none of the relevant PML domains appeared to be crucial for the PML growth suppressive activity, we investigated whether they might mediate independent eects on cell growth. The answer was sought by independently expressing the PML aminoterminal cysteine-histidine rich region or the cysteine-histidine rich plus coiled-coil regions in the U20S cells. These two PML mutants were, however, not able to enter the nucleus (data not shown), probably because they both lacked the PML putative NLS, which has been mapped between AA 448 and 494 (Flenghi et al., 1995; Kastner et al., 1992) . To target these two mutants to the nucleus we ®rst demonstrated that the 448 ± 494 region is involved in nuclear targeting of PML by adding this sequence to a diusible protein, the green¯uorescence protein (GFP) and analysing its cellular distribution. The GFP is a highly¯uorescent protein of the bioluminescent jelly®sh Aequora victoria which emits green light upon excitation with ultraviolet or blue light (Chal¯e et al., 1994) . Here we used a mutant of GFP (Ser65→Thr) which emits a brighter green light (the emission spectra is seven time higher than the wild-type GFP) upon excitation with only blue light (Heim et al., 1995) . Its expression into mammalian cells results in a diuse cytoplasmic and nuclear¯uorescent pattern (Rizzuto et al., 1995 and Figure 5 ) that can be seen both in ®xed and living transfected cells. Addition of the PML NLS to the GFP protein (GT1 construct, Figure 4a ) gave an exclusively nuclear¯uorescent pattern ( Figure 5 ). Next the GT1 polypeptide was fused to the PML aminoterminal cysteine-histidine rich region (GT2 construct), to the PML cysteine-histidine rich plus coiled-coil regions (GT8 construct) and to the full-length PML3 (PMLB1 construct) (Figure 4a ). The resulting GFP-fusion proteins were transfected into U2OS cells and analysed for their localization ( Figure  5 ). The GT2 construct gave a nuclear diuse pattern of staining, with the exclusion of nucleoli, while the GT8 stained within NBs, morphologically indistinguishable from those of the PMLB1 protein ( Figure 5 ). The GT1, GT2, GT8 and PMLB1 plasmids were then used to perform a colony formation assay, using U2OS cells, as previously described. The levels of expression, as determined by Western blot analysis 48 h after transfection, were roughly the same for all GFPfusion proteins (Figure 4b ). The results, expressed as percentage of cloning eciency with respect to the control GT1, demonstrated that the cysteine-histidine region alone (GT2) had a slight but consistent growth suppressive activity while the cysteine-histidine plus the coiled coil (GT8) had a near wild-type eect ( Figure  4c ). It, therefore, appears that the cysteine-histidine rich region exerts a weak, yet independent, activity on growth regulation and that its fusion with the coiledcoil region is sucient to recapitulate the suppressive function of wild type PML. In summary, these data, together with those described in the previous paragraph showing that individual deletions of the various PML domains have no eect on its growth suppressor activity, suggest that the three PML domains have independent and additive signalling potential toward growth regulation.
Cellular localization of PML mutants
To determine whether the growth suppressive eect of PML requires integrity of the NBs, we analysed the cellular localization of the various PML mutants after transient transfection in mouse NIH3T3 ®broblasts. As our anti-PML antibodies do not recognize mouse PML, they allow selective monitoring of exogenous PML expression (Flenghi et al., 1995) . The DCPML3 and DHPML3 mutants produced a diuse nuclear (Figure 6b and c,  respectively) , while the PML-PR yielded a speckled pattern with larger and less numerous NBs (Figure 6d) than in the transfected wt PML (Figure 6a ). The localization of these mutants is consistent with that observed with the various GFP-PML fusion proteins ( Figure 5 ). In particular, the GT8 and the PML-PR mutants, both lacking the PML C-terminal region, gave a similar speckled pattern of nuclear localization. In summary, the results indicate that the RING+B1-B2 and the coiled-coil are required and sucient for PML NB targeting since DCPML3, DHPML3 and the GT2 mutants are nuclear diuse and the GT8 mutant is speckled. Furthermore, targeting to NBs is not necessary for the PML growth suppressive eect since two growth suppressor PML mutants (DCPML3 and DHPML3) had a diuse and two others (GT8 and PML-PR) a speckled patterns of localization.
Discussion
We provided evidence that overexpression of PML potently suppresses growth in various cell lines and that the mechanism underlying growth suppression is induction of apoptotic cell death. Other groups have reported that PML overexpression exerts a negative eect on the cellular transformation triggered by certain oncogenes (neu) and cooperative oncogenes (Ha-Ras plus myc, Ha-Ras plus mutated p53) Mu et al., 1994 ). Since we demonstrated that PML overexpression aects growth rather than transformation, and that this eect is also evident in non-transformed cells, the previously described antitransformation potential of PML might be the consequence of a more general eect on cell growth.
The relevance of these data with regard to the physiological function of PML is not clear, as the PML-antiproliferative eect was established in nonphysiological conditions, e.g. upon expression of the PML gene under the control of a heterologous promoter. Analysis of PML expression in normal tissues revealed that it is mainly expressed in postmitotic cells (Flenghi et al., 1995; Gambacorta et al., 1996) . In addition, PML-NBs have been shown to be target of DNA viruses (Carvalho et al., 1995; Doucas et al., 1996; Everett and Maul, 1994; Puvion-Dutilleul et al., 1995) and PML itself is up-regulated by the antiproliferative and anti-viral agent interferon (ChelbiAlix et al., 1995; Lavau et al., 1995; Stadler et al., 1995) and forms stable complexes with the adenovirus E1A transforming protein (Alcalay et al., 1998) . All together these ®ndings suggest that PML is physiologically involved in negative growth regulation, possibly by modulating cell survival.
To investigate the molecular mechanisms through which PML induces growth suppression, we have analysed the biological activity of dierent PML isoforms and mutants. Several PML isoforms have been identi®ed that dier for their carboxy-terminal region (Fagioli et al., 1992) . They all contain a putative NLS and localize to the nucleus, with the exception of the PML 3-4-7 isoform that lacks the NLS and localizes to the cytoplasm (Flenghi et al., 1995) . The nuclear PML1, PML2 and PML3 isoforms showed a potent growth suppressive activity, while the cytoplasmic PML 3-4-7 isoform had no eect on cell growth, thereby suggesting that PML exerts its biological activity within the nucleus. We have then investigated Figure 3c . In fact, in a set of separate experiments, we have documented that the GT1 and pCDNA3 constructs and the PMLB1 and PML3 constructs scored similarly in colony formation assays using U20S cells (data not shown) the biological activity of various nuclear PML mutants which were designed to explore the relevance of three regions of the PML protein: the Ring ®nger and the B1-B2 boxes; the coiled-coil region, which is a proteinprotein dimerization interface; the carboxy-terminal region, that corresponds to the region of PML lost during the recombination with RARa in the t(15;17) translocation. None of these regions appears to be indispensable for the growth suppressive eect of PML, since individual deletions had no eect on the biological activity of PML. However, since growth inhibitory activity was weak, though consistent, with the RING+B1-B2 region alone, while it was fully expressed by the RING+B1-B2 plus coiled-coil regions, they may exert both independent and cooperative eects on growth.
The mechanisms through which PML overexpression aects cell growth are not clear. Although the PML RING ®nger has no assigned function, RING domains of two other proteins (TIF1 and BRCA1) are thought to act as protein-protein interaction domains (Friedman et al., 1996; Wu et al., 1996) . The coiled-coil region of PML has been shown to be a protein-protein interaction domain (Kastner et al., 1992) . The B1 and GFP GT1 GT2 GT8 PMLB1 Figure 5 Cellular localization of PML-GFP fusion proteins in NIH3T3 cell line. Cells were transiently transfected with the indicated cDNAs using calcium phosphate precipitation procedure. The GFP¯uorescence was detected after ®xation of cells with 3.7% paraphormaldeide for 10 min and methanol for 5 min at room temperature (upper panels); the lower panels show the overlapped images, by software, of 4',6-diamidino-2-phenylindole (DAPI) staining (for identi®cation of nuclear morphology) and GFP Figure 6 Immuno¯uorescence analysis of the wt and mutant PML localization in NIH3T3 cells. Cells were transiently transfected using the calcium phosphate precipitation procedure and then stained with two dierent antibodies: PG-M3 to stain PML3 (a), DHPML3 (c) and PML-PR (d) mutant proteins and PG to stain the DCPML3 mutant protein (b) B2 boxes and the carboxy-terminal regions also have no assigned functions. However, we have recently proved that they are involved in the formation of PML-Rb complex (Alcalay et al., 1998) . It may, therefore, be that the three PML domains direct multiple protein-protein interactions which are involved in the growth suppressive function of PML. The PML/Rb interaction, however, does not appear to be involved since PML overexpression induces growth suppression in Rb7/7 cells, as well (Alcalay et al., 1998) . It has previously been reported that the capacity of PML to suppress neoplastic transformation depends on its localization to the NBs (Le et al., 1996) . We have demonstrated that the RING, B1+B2, the coiled-coil of PML are both indispensable and sucient to target PML to the NBs. Fusion of these regions to a diusible protein, such as the GFP, target the GFP to the NBs and individual deletions of these regions abrogate the NB localization of PML. However, although some of the PML mutants that are targeted to the NBs are biologically active, others exhibit similar biological activity and a nuclear diuse localization. In summary, the PML regions involved in NB targeting and growth suppression do not completely overlap.
The lack of correlation between NB localization and the growth suppressive eect suggests that the NBs are not the only active sites of PML. Biochemical analysis of PML cell distribution by fractionation experiments (unpublished results) have revealed that the wild-type and carboxy-terminal deleted PML molecules are predominantly localized in the nuclear matrix and less in the soluble nuclear fraction. Since both proteins localize to NBs, this correlates with previously reported ®ndings that PML-NBs are matrix-associated . On the other hand, the PML mutants with deletions of the cysteine-histidine or coiled-coil regions are nuclear diuse and mainly localized to the soluble nuclear fraction, with only a minor component associated with the nuclear matrix. Overall these data suggest that the PML that is localized to the matrixassociated NBs and the nuclear diuse and soluble PML are both involved in transducing negative signals to cell growth.
The data presented here have important implications for understanding the mechanisms through which the PML/RARa protein exerts its biological activities. The current hypothesis is that fusion with RARa results in the loss of the PML growth suppressive function and that PML/RARa inactivates the endogenous PML growth suppressive activity by destroying the PML-NBs (Le et al., 1996) . A number of ®ndings argue against this hypothesis: (i) the PML portion of the PML/RARa fusion protein (PML-PR mutant) retains growthsuppressive activity; (ii) the NBs are not the only active sites of the PML protein; (iii) PML/RARa increases survival of a subset of haematopoietic cells Rogaia et al., 1995) , but suppresses growth of all other cell types tested (Ferrucci et al., 1997) . An alternative hypothesis is that PML/RARa incorporates the biological activity of PML. This would result in the capacity of PML/ RARa to induce cell death in every cell type, except in a subset of haemopoietic cells, where it, instead, promotes survival. In the latter, the PML portion of the fusion protein might acquire survival-stimulating functions as a consequence of its fusion with RARa and physical or functional interactions with tissue speci®c factors. The identi®cation of haematopoieticspeci®c PML/RARa interacting proteins would help clarify this issue.
Materials and methods
PML mutants and expression vectors
The various PML2 and PML3 mutants were obtained from the PML M51 and M58 clones (Fagioli et al., 1992) , respectively by PCR base technologies and controlled by DNA sequence. For the DH mutants construction the two PML sequences¯anking the coiled-coil region were PCR ampli®ed with the oligonucleotides 5'-GGATGCCTG-GAGGCGTCGGGC-3' and 5'-GTCGCACTCGAGCTC-ACTGT-3'; 5'-CTGCCGCCTGCGCCTCGAGGA-3' and 5'-TCGGGCAGGTCAACGTCAAT-3'. The two fragments were ligated through the XhoI sites introduced by PCR (underlined). The resulting PML fragment, which lacked aminoacids 226 ± 361, was introduced in the PML2 M51 and PML3 M58 cDNAs between SphI and HincII. To obtain the DC mutant the PML region from bp 721 ± 881 (primers: 5'-CTTGACAGCGCCACCATGGAGCTCA-3' and 5'-GCGCGGCCCAGCTGGCCGACG-3') was ampli®ed and substituted to the 5' PML3 M58 sequences at the S®I site. The 5' oligonucleotides contained a start codon (underlined) in the context of a Kozak consensus. The PML-PR cDNA, encoding a PML protein truncated at the aminoacid 553, was constructed by substituting, at the HincII site, the 3' portion of a PCR-modi®ed PML cDNA carrying a TAG stop codon (primers: 5'-AGAGCCTGC-AAGCTGCCGT-3' and 5'-ACAACGGGATCCTATG-CCT-3'; the stop codon is underlined). PML 3-4-7 clone has just been described (Fagioli et al., 1992) . Using oligo NLS1 (from 1403 to 1421 bp: 5'-AGTCAGTGCCCGGG-GCACA-3') and NLS2 (from 1556 to 1537: 5'-TCCTCA-GATCACATCTTGAT-3'), the region containing the putative PML nuclear localization signal was engineered to contain a 5' SmaI site (underlined in oligo NLS 1) and a 3' stop codon (bold typed in oligo NLS2) and then ligated to the 3' extremity of GFP cDNA (Chal¯e et al. 1994) ) by blunt-end ligation into aEcoRV site that mutagenized the GFP TGA stop codon. The resulting GFP-NLS construct (GT1) was modi®ed to introduce a SacI 5' site at the ATG start codon and then ligated to the EcoRI ± SacI 740 bp and to the EcoRI ± SacI 1162 bp fragement of PML3 M58 clone to produce the GT2 and the GT8 cDNA clones, respectively. The PMLB1 cDNA clone was obtained by introducing a BamHI site at the TGA site of PML3 and at the ATG of GFP. All the described mutants and the PML1, PML2 and PML3 (Fagioli et al., 1992) cDNAs were subcloned into the pCDNA3 (Invitrogen, De Schelp 12, 9351 NV Leek, The Netherlands) or pMT expression vectors.
Cell culture and transfection
Cell lines that grown in suspension were maintained in RPMI 1640 medium supplemented with 10% FCS plus appropriated growth factors and then transfected by electroporation. Cells were selected in G418 and subcloned under limiting dilution conditions. All adherent cell lines were cultured in Dulbecco modi®ed Eagle's medium supplemented with 10% FCS, except NIH3T3 which was cultured in 10% BCS. The cells were then transfected by the calcium phosphate precipitation procedure.
Western blotting
Western blot analysis was performed as described on dierent cell lysates using the PG-M3 (Flenghi et al., 1995) or PG anti-PML antibodies and revealed by the ECL method (Amersham, Little Chalfont, UK).
Colony formation assay
U20S, C33a, SAOS, HeLa, NIH3T3 and PEF cells were plated at a concentration of 5610 5 in a 10 cm plate and transfected with 10 mg of cloned or control DNAs. After 48 h cells were splitted 1 : 25, 1 : 50 and 1 : 100 and subcoltured into medium containing 500 mg/ml of G418. A small amount was plated in chamber slides (Nunc Inc., Naperville, Illinois, USA) to perform anti-PML immunouorescence staining to verify transfection ecency. Drug resistant colonies that appeared 14 ± 21 days later were either isolated for further analysis or quanti®ed after being stained with crystal violet.
Immuno¯uorescence staining U937 cells were collected before or after 100 mM ZnSO 4 treatment, cytocentrifuged and ®xed in methanol at room temperature for 5 min followed by acetone at 7208C for 2 min. Adherent cells were plated in chamber slides and ®xed in paraformaldehyde 3.7% for 10 min followed by methanol for 5 min at room temperature. PML staining was performed with three dierent antibodies: the PG-M3 monoclonal antibody, directed against the PML Nterminal region (Flenghi et al., 1995) ; the PG serum, against aminoacids 228 ± 388 of the the a-helix (a gift from P Greer); the anti PML-3 serum against the PML3 unique C-terminal region (aminoacids 592 ± 607) (Fagioli et al., 1992) . Cells were then stained with FITC-or rhodamineconjugated anti-mouse or anti-rabbit Ig antibodies (Southern Biotechnology Associates, Birmingham, AL, USA).
Preparations were examined on a Olympus BX-60 ourescence microscope equipped with a chilled 3CCD digital colour camera (C5810 Hamamatsu Photonics, Japan). Images were captured with a 24-bit board (Image grabber 24, Neotech, London UK) on a 8100/80 Power Macintosh computer (Apple, Cupertino, USA). For colocalization experiments, the same microscopic ®elds were examined with distinct cubes for¯uorescein (excitation ®lter 470 ± 490, dichroic mirror 505, barrier ®lter 515 ± 550 nm) and rhodamine (excitation ®lter 510 ± 550, dichroic mirror 570, barrier ®lter 590 nm). The images were directly superimposed by the C5810 3CCD control unit.
Cell growth, cell cycle phase distribution and apoptosis U937 cells were plated at 2610 5 per ml in RPMI with 10% FCS in the presence and absence of 100 mM ZnSO 4 . Proliferation was evaluated by direct cell counting (trypan blue exclusion method). At various time points, the cells were analysed for cell cycle distribution by¯ow cytometric analysis of propidium iodide-stained nuclei, as described (Pagliacci et al., 1993) . To identify apoptosis cells were collected, cytocentrifuged, ®xed in 1% paraformaldehyde and subjected to TdT (terminal-deoxynucleotidyl transferase) assay (Gorczyca et al., 1993) .
